Compare ONON & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONON | MEDP |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | Switzerland | United States |
| Employees | N/A | 6300 |
| Industry | Shoe Manufacturing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.9B |
| IPO Year | 2021 | 2016 |
| Metric | ONON | MEDP |
|---|---|---|
| Price | $37.40 | $417.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 12 |
| Target Price | $60.15 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 5.7M | 458.7K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 4.28 |
| Revenue | N/A | N/A |
| Revenue This Year | $19.58 | $13.19 |
| Revenue Next Year | $19.98 | $7.75 |
| P/E Ratio | ★ $56.05 | $98.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.41 | $287.17 |
| 52 Week High | $61.29 | $628.92 |
| Indicator | ONON | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | 39.23 |
| Support Level | $34.38 | $412.35 |
| Resistance Level | $37.89 | $435.15 |
| Average True Range (ATR) | 1.45 | 11.85 |
| MACD | 0.30 | 0.52 |
| Stochastic Oscillator | 96.68 | 47.13 |
Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.